BLRX vs CGEN: Side-by-Side Comparison
Compare Bioline Rx Ltd (BLRX) and Compugen Ltd (CGEN) side by side: market cap USD 14.29M vs USD 215.58M. Financials, growth and model signals on Bullrun.
| Metric | BLRX | CGEN |
|---|---|---|
| Company | Bioline Rx Ltd | Compugen Ltd |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 14.29M | USD 215.58M |
| P/E ratio | — | 6.2 |
| Dividend yield | — | — |
| Valuation model | — | 101.6% undervalued |
| Revenue (latest FY) | — | USD 72.76M |
| Revenue growth YoY | — | +161.1% |
| Net income | — | USD 35.34M |
| Gross margin | — | 87.3% |
| Diluted EPS | — | 0.38 |